Optimizing Dry Eye Disease Management: Exploring Unmet Treatment Needs

Jai G. Parekh, MD, MBA; and Alexander Kabiri, OD; explore the current treatment landscape of dry eye disease.

Adverse reactions and challenges with patient adherence to therapy are explored by dry eye disease experts.

The expert panel provides perspective on current therapeutic gaps and key barriers to care.

Experts underscore the importance of patient-reported outcomes in tailoring treatments for dry eye disease in patients.

Professionals highlight considerations for the addition of cost-effective, statistically significant therapies to payer formularies.

Key opinion leaders highlight the importance of identifying and treating dry eye disease to mitigate long-term economic burdens.

Experts provide a perspective on disparities in accessibility and outcomes based on the current socioeconomic landscape in health care.

A panel of medical experts discuss the shift from intervention to prevention in the management of dry eye disease, as well as perspectives on resource allocation.

Panelists underscore the importance of patient education in improving treatment adherence.

Experts examine the economic burdens on the health care system, payers, and patients, based on associated costs with dry eye disease.

Medical experts explore recent therapies in the treatment of dry eye disease.

Jai G. Parekh, MD, MBA; and Alexander Kabiri, OD; compare emerging therapies and traditional treatments for dry eye disease.

A professional analysis of the potential cost-effective impact of emerging dry eye therapies on the health care system.

Key opinion leaders share their final thoughts on advancing treatments of Dry Eye Disease.